Biotech · Private company · St. Paul, MN, US
Marpam Pharma, LLC
Track this companyFree. Adds Marpam Pharma, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- A novel CAR-T cell therapy for the one-time treatment of chronic HIV infection in patients who are not ART suppressedFiscal year 2025 · $979.1KNIH RePORTER 5R42AI167175-03 · fetched Nov 12, 2026
- Proof of concept studies for in vivo produced CAR-T cells that target B cell follicles as a treatment for HIVFiscal year 2024 · $302.2KNIH RePORTER 1R41AI184054-01 · fetched Nov 12, 2026
- A novel CAR-T cell therapy for the one-time treatment of chronic HIV infection in patients who are not ART suppressedFiscal year 2024 · $1MNIH RePORTER 4R42AI167175-02 · fetched Nov 12, 2026